##  [Novartis Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis](/us-en/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis-0 "Novartis Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis") 

  Jun 17, 2020